644
Participants
Start Date
March 31, 2009
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Nilotinib (AMN107)
imatinib (STI571)
Novartis Investigative Site, Taipei
Novartis Investigative Site, Caracas
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Sofia
Novartis Investigative Site, Johannesburg
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Wels
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Cape Town
Novartis Investigative Site, Graz
Novartis Investigative Site, Varna
Novartis Investigative Site, Taipei
Novartis Investigative Site, Candiolo
Novartis Investigative Site, Torino
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Bangkok
New York Oncology Hematology, P.C. NYOH Amsterdam, Troy
New York Oncology Hematology, P.C. NYOH@AlbanyMedicalCenter(2), Troy
Novartis Investigative Site, Marseille
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Bad Saarow
Novartis Investigative Site, Genova
Washington Hospital Center Wash Hospital, Washington D.C.
Novartis Investigative Site, Milan
Novartis Investigative Site, Madrid
Novartis Investigative Site, Hanover
Novartis Investigative Site, Chihuahua City
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Oviedo
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Aviano
Novartis Investigative Site, Linkou District
Ocala Oncology Center Dept. of Ocala Oncology Center, Ocala
Novartis Investigative Site, Kartal
Novartis Investigative Site, Izmir
Birmingham Hematology and Oncology Associates, Birmingham
Novartis Investigative Site, Balcova / Izmir
Novartis Investigative Site, León
Novartis Investigative Site, Chambray-lès-Tours
Vanderbilt Univeristy Ingram Cancer Ctr., Nashville
Novartis Investigative Site, Khon Kaen
Novartis Investigative Site, Bologna
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Modena
Novartis Investigative Site, Saint-Herblain Cédex
Novartis Investigative Site, Essen
Novartis Investigative Site, Florence
Novartis Investigative Site, Vandœuvre-lès-Nancy
Minnesota Oncology Hematology, P.A. SC, Minneapolis
Mayo Clinic - Rochester Division of Hematology, Rochester
Northwestern University Clinical Research Office (2), Chicago
Novartis Investigative Site, Mannheim
Novartis Investigative Site, Lyon
Novartis Investigative Site, San Giovanni Rotondo
Texas Oncology Wichita Falls, Dallas
Novartis Investigative Site, Paris
Tyler Cancer Center Dept.ofTylerCancerCtr. (2), Tyler
Texas Oncology, P.A. Tex Onc (2), Bedford
Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2), San Antonio
University of Colorado Dept. of Univ. of Colorado, Aurora
Novartis Investigative Site, München
Novartis Investigative Site, Niaosong Township
Novartis Investigative Site, Bratislava
Kootenai Medical Center Dept.ofKootenai Med.Ctr., Coeur d'Alene
University of Utah / Huntsman Cancer Institute Dept.ofHuntsmanCancerInst.(3), Salt Lake City
Northern Arizona Hematology/Oncology Associates, P.C. Dept. of No. AZ Hem-Onc, Flagstaff
University of California at Los Angeles GI Oncology Program, Los Angeles
Novartis Investigative Site, Songkhla
Novartis Investigative Site, Palermo
Novartis Investigative Site, Weiden
Stanford University Medical Center Stanford Cancer Center, Stanford
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Singapore
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Craiova
Novartis Investigative Site, Nanjing
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Iași
Novartis Investigative Site, Haifa
Novartis Investigative Site, Ramat Gan
City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(4), Duarte
City of Hope National Medical Center Regulatory Document, Duarte
University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (2), La Jolla
Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer, Greenwood Village
Novartis Investigative Site, Pereira
Novartis Investigative Site, Alexandria
Novartis Investigative Site, Cairo
Novartis Investigative Site, Hong Kong SAR
Dana Farber Cancer Institute Centerfor Sarcoma&BoneOncology, Boston
University of Michigan Comprehensive Cancer Center DeptofMichiganCancerCenter(6), Ann Arbor
University of Pennsylvania Medical Center CAMN107G2301, Philadelphia
University of Texas Southwestern Medical Center DeptofSimmons Cancer Center(3), Dallas
University of Texas/MD Anderson Cancer Center Dept. of MD Anderson (13), Houston
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Caba
Novartis Investigative Site, Rosario
Novartis Investigative Site, Leoben
Novartis Investigative Site, Vienna
Novartis Investigative Site, Uberlândia
Novartis Investigative Site, Florianópolis
Novartis Investigative Site, Campinas
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Halifax
Novartis Investigative Site, Hamilton
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Montreal
Novartis Investigative Site, Québec
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Århus C
Novartis Investigative Site, Herlev
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Gifu
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Sendai
Novartis Investigative Site, Niigata
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Osaka
Novartis Investigative Site, Suita
Novartis Investigative Site, Sunto-gun
Novartis Investigative Site, Chuo-ku
Novartis Investigative Site, Toyama
Novartis Investigative Site, Leiden
Novartis Investigative Site, Oslo
Novartis Investigative Site, Krakow
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Pretoria
Novartis Investigative Site, Suwon
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Linköping
Novartis Investigative Site, Lund
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Umeå
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Adana
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Newcastle upon Tyne
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Glasgow
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY